NSE filing, NSE: NEOCHEM. Summary written from the filing by ALFA Finder's alert engine.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹105.10
- Market cap
- ₹179.9 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 15.0×Sector 34.1×
- Promoter holding
- 66.88%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Earnings Call Transcript: Key Takeaways
Neochem Bio Solutions is a specialty chemical manufacturer reporting strong H1 FY25 growth, achieving ₹4,718 Lakh income with 18.75% EBITDA margin, focusing on Textile, HPC, and sustainable bio-based formulations.
Neochem Bio Solutions Investor Presentation: Key Takeaways
H1 FY27 revenue ₹68.9 cr (+50% y-o-y), PAT ₹7.8 cr (+43%), but EBITDA margin fell to 18.0% from 21.7%. Strategy centres on diversification and bio-based chemistries.
Neochem Bio Solutions Management Change
Neochem Bio Solutions appointed Harshit Shah as CFO and Vikram Nair as CCO effective October 27. Solanki was redesigned from CFO to Senior VP Finance.
Neochem Bio Solutions H1 FY27 Results: Net Profit ₹7.8 Cr, Up 41.8% YoY
Neochem Bio Solutions Ltd reported revenue from operations of ₹68.9 Cr (+50.4% YoY) and net profit of ₹7.8 Cr (+41.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · +41.8% YoY
Neochem Bio Solutions Other Announcement
Neochem Bio Solutions Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter and half-year ended September 30, 2026, as per SEBI regulations.
Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
Other board meeting date announcements
All →Lead Reclaim and Rubber Products Board Meeting Date
Lead Reclaim will meet on 05 November 2026 to consider half-yearly unaudited results for September 2026. Trading window remains closed until 07 November 2026.
Oval Projects Engineering Board Meeting Date
Oval Projects Engineering will hold a board meeting on November 4, 2026 to consider half-year results and a warrant issue. Agenda items are proposed; no amount stated.
Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.